How to use scorecard? Learn more
Nippon India Pharma Fund
Price Chart
How to use scorecard? Learn more
Key Metrics
| Expense RatioExpense Ratio | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 0.91 | 51.31 | 2.34 |
| No LabelNo Label | No LabelNo Label | No LabelNo Label |
|---|---|---|
| 1.47 | 52.81 | 2.45 |
Scheme Info
| PlanPlan | Lock inLock in | Exit LoadExit Load |
|---|---|---|
| Growth | 0 yrs | 1.00% |
| SIP Inv.SIP Inv. | Min. LumpsumMin. Lumpsum |
|---|---|
| Allowed | ₹ 5,000 |
| BenchmarkBenchmark |
|---|
| BSE Health Care - TRI |
About Sectoral Fund - Pharma & Health Care
Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.
Peers & Comparison
EquitySectoral Fund - Pharma & Health Care
Returns
Scheme
Ratios
| Mutual Fund | 1Y Returns1Y Returns | 3Y CAGR3Y CAGR | Life CAGRLife CAGR |
|---|---|---|---|
| Nippon India Pharma Fund | 35.41% | 19.48% | 19.04% |
| ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund | 47.35% | 24.19% | 24.33% |
| SBI Healthcare Opp Fund | 44.62% | 24.50% | 18.89% |
| DSP Healthcare Fund | 48.23% | 23.13% | 28.30% |
Price Comparison
Compare Nippon India Pharma Fund with any MF, ETF, stock or index
Hmm, looks like data is unavailable here. Please come back after some timeAsset Allocation
Actual
Target
Mar 2024
Jun 2024
Sep 2024
Oct 2024
ACTUAL
Mar 2024
Jun 2024
Sep 2024
Oct 2024
Sector Distribution
Mar 2024
Jun 2024
Sep 2024
Oct 2024
Sector Weightage
Current Holdings
Equity
Others
- ConstituentHolding Weight3M Change
- Sun Pharmaceutical Industries Ltd3M change : 0.10 %
Holdings
13.95 %
0.10 % - Divi's Laboratories Ltd3M change : 0.99 %
Holdings
9.16 %
0.99 % - Lupin Ltd3M change : 0.54 %
Holdings
8.06 %
0.54 %
AMC Profile
Nippon India Mutual Fund is one of India’s leading mutual funds, with Average Assets Under Management (AAUM) of Rs 2,79,431 Crores. NIMF has been established as a trust under the Indian Trusts Act, 1882 with Nippon Life Insurance Company as its Sponsor and Nippon Life India Trustee Ltd as its Trustee.
No.of Schemes
78
Total AUM
₹ 4,14,348.48 Cr.
Fund Manager Profile
Sailesh Raj Bhan
AUM: ₹81,551.42 Cr.
|
Exp: 10yrs
Qualification
MBA (Finance), CFA (ICFAI)
Past Experience
Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date
Funds Managed (6)
Manager Performance (0)
Tax Implications
Let’s calculate your returns after tax
Investment frequency
Monthly
One Time
Monthly Investment Amt. (₹)
Investment period (years)
You make
Opinions and Fund Reviews
Top 3 Best Healthcare Fund 2021 | Should You Invest In Pharma Funds ?
3 years ago•Banking Mastery
My returns from Nippon Pharma are at 65 per cent. Should I exit?
4 years ago•Value Research
Q&A with Dhirendra Kumar on Aug 29, 2020
4 years ago•Value Research
Nippon India Pharma Fund - Sailesh Raj Bhan | Nippon India | Mutual Fund Watch | EP 10
4 years ago•Groww Mutual fund
Top 3 Healthcare Sector Mutual Fund to invest after Corona virus market crash 2020 | Corona virus
4 years ago•Time To Invest
What are the Types of Sector Fund?
6 years ago•Groww
Invested period < 1 year
Gains are treated as short-term capital gains and taxed at 20%
Invested period > 1 year
Gains are treated as long-term capital gains and taxed at 12.5%